Pathological Complete Response Following Neoadjuvant Tislelizumab Monotherapy in Treatment-Naive Locally Advanced, MMR-Deficient/MSI-High Ascending Colon Cancer: A Case Report
Journal of Clinical Medicine（2022）
Key words
neoadjuvant immunotherapy,locally advanced colorectal cancer,tirelizumab,mismatch repair deficient,pathological complete response
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined